Cargando…
Molecular chess? Hallmarks of anti-cancer drug resistance
BACKGROUND: The development of resistance is a problem shared by both classical chemotherapy and targeted therapy. Patients may respond well at first, but relapse is inevitable for many cancer patients, despite many improvements in drugs and their use over the last 40 years. REVIEW: Resistance to an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214767/ https://www.ncbi.nlm.nih.gov/pubmed/28056859 http://dx.doi.org/10.1186/s12885-016-2999-1 |